ConductScience.org, home

Paper8147264

The effect of a cyclooxygenase inhibitor on the in vivo polymorphonuclear leukocyte migration to Pseudomonas aeruginosa peptide chemotactins.

Fontán PA and 2 others. Agents Actions, 1993. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. The effect of a cyclooxygenase inhibitor on the in vivo polymorphonuclear leukocyte migration to Pseudomonas aeruginosa peptide chemotactins. Papers, record 8147264. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8147264

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The effect of a cyclooxygenase inhibitor on the in vivo polymorphonuclear leukocyte migration to Pseudomonas aeruginosa peptide chemotactins.
PubMed
Journal
Agents Actions
PubMed
Year
1993
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
3
iCite
Relative citation ratio, by iCite
0.1
iCite
Revised in PubMed
2019-08-25
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Fontán PAP A
2Amura CRC R
3Sordelli DOD O

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Chemotactic FactorsMajor topic
Chemotaxis, LeukocyteMajor topic
Cyclooxygenase InhibitorsMajor topic
NeutrophilsMajor topic
PiroxicamMajor topic
Pseudomonas aeruginosaMajor topic
Aerosols
Animals
Bronchoalveolar Lavage Fluid
Culture Media
Lung
Mice
N-Formylmethionine Leucyl-Phenylalanine

Source PubMed

Download CSV of topics

References13

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
13546374Tissue injury in inflammation. Oxidants, proteinases, and cationic proteins.J Clin Invest1987https://conductscience.org/library/papers/3546374PubMed
23279020The chemotactic peptide receptor. A model for future understanding of chemotactic disorders.Hematol Oncol Clin North Am1988https://conductscience.org/library/papers/3279020PubMed
46368592Proteases and oxidants in experimental pulmonary inflammatory injury.J Clin Invest1984https://conductscience.org/library/papers/6368592PubMed
53863757Ibuprofen modifies the inflammatory response of the murine lung to Pseudomonas aeruginosa.Eur J Respir Dis1985https://conductscience.org/library/papers/3863757PubMed
62915154Piroxicam treatment protects mice from lethal pulmonary challenge with Pseudomonas aeruginosa.J Infect Dis1989https://conductscience.org/library/papers/2915154PubMed
71312519Age-dependent pulmonary clearance of Pseudomonas aeruginosa in a mouse model: diminished migration of polymorphonuclear leukocytes to N-formyl-methionyl-leucyl-phenylalanine.Infect Immun1992https://conductscience.org/library/papers/1312519PubMed
83821519NADH oxidase from guinea pig polymorphonuclear leukocytes.Methods Enzymol1986https://conductscience.org/library/papers/3821519PubMed
92596837Pseudomonas aeruginosa pneumonia. Treatment with nonsteroidal anti-inflammatory agents to prevent lung tissue damage.Antibiot Chemother (1971)1989https://conductscience.org/library/papers/2596837PubMed
103920067Inflammatory responses to Pseudomonas aeruginosa and Staphylococcus aureus in the murine lung.Eur J Respir Dis1985https://conductscience.org/library/papers/3920067PubMed
111587615Preliminary characterization of Pseudomonas aeruginosa peptide chemotactins for polymorphonuclear leukocytes.Infect Immun1992https://conductscience.org/library/papers/1587615PubMed
121846066Sepsis-induced lung injury and the effects of ibuprofen pretreatment. Analysis of early alveolar events via repetitive bronchoalveolar lavage.Am Rev Respir Dis1991https://conductscience.org/library/papers/1846066PubMed
132055839Initial recruitment of neutrophils to alveolar structures in acute lung injury.J Appl Physiol (1985)1991https://conductscience.org/library/papers/2055839PubMed
143076883Oxygen radicals, inflammation, and tissue injury.Free Radic Biol Med1988https://conductscience.org/library/papers/3076883PubMed

Download CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn Papers
17221337Eicosanoid regulation of pulmonary innate immunity post-hematopoietic stem cell transplantation.Arch Immunol Ther Exp (Warsz)2007https://conductscience.org/library/papers/17221337

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8147264

GET https://conductscience.org/api/papers/v1/8147264/authors